These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6309425)

  • 1. Phase II study of chlorozotocin in islet cell carcinoma. A southwest Oncology Group study.
    Bukowski RM; McCracken JD; Balcerzak SP; Fabian CJ
    Cancer Chemother Pharmacol; 1983; 11(1):48-50. PubMed ID: 6309425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II trial of chlorozotocin and fluorouracil in islet cell carcinoma: a Southwest Oncology Group study.
    Bukowski RM; Tangen C; Lee R; Macdonald JS; Einstein AB; Peterson R; Fleming TR
    J Clin Oncol; 1992 Dec; 10(12):1914-8. PubMed ID: 1333517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinoma.
    Moertel CG; Lefkopoulo M; Lipsitz S; Hahn RG; Klaassen D
    N Engl J Med; 1992 Feb; 326(8):519-23. PubMed ID: 1310159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II trials of maytansine, low-dose chlorozotocin, and high-dose chlorozotocin as single agents against advanced measurable adenocarcinoma of the pancreas. Gastrointestinal Tumor Study Group.
    Cancer Treat Rep; 1985 Apr; 69(4):417-20. PubMed ID: 2859924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II trial of methyl-CCNU, vincristine, 5-fluorouracil, and streptozotocin (MOF-Strep) in patients with disseminated pancreatic carcinoma.
    Sordillo PP; Magill GB
    Am J Clin Oncol; 1982 Jun; 5(3):277-9. PubMed ID: 6282110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic islet cell carcinoma. II. Results of therapy with streptozotocin in 52 patients.
    Broder LE; Carter SK
    Ann Intern Med; 1973 Jul; 79(1):108-18. PubMed ID: 4352784
    [No Abstract]   [Full Text] [Related]  

  • 7. Combination chemotherapy for islet cell carcinoma and metastatic carcinoid tumors with 5-fluorouracil and streptozotocin.
    Chernicoff D; Bukowski RM; Groppe CW; Hewlett JS
    Cancer Treat Rep; 1979 May; 63(5):795-6. PubMed ID: 222449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II evaluation of chlorozotocin in metastatic sarcomas.
    Presant CA; Bartolucci AA
    Med Pediatr Oncol; 1984; 12(1):25-7. PubMed ID: 6230516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chlorozotocin: results in colorectal carcinoma treated with high and low doses. A Southwest Oncology Group study.
    Haas CD; McCracken JD; Vaughn CB; Stephens RL; Bukowski RM; Eyre HJ
    Invest New Drugs; 1984; 2(4):401-4. PubMed ID: 6239836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Streptozotocin in hormone-active metastasizing islet-cell carcinoma].
    Spech HJ; Wernze H; Brunswig D
    Med Klin; 1973 Apr; 68(17):555-9. PubMed ID: 4350157
    [No Abstract]   [Full Text] [Related]  

  • 11. Phase II study of chlorozotocin in malignant melanoma: a Southeastern Cancer Study Group report.
    Van Amburg AL; Presant CA; Burns D
    Cancer Treat Rep; 1982 Jun; 66(6):1431-3. PubMed ID: 6211234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Streptozotocin therapy for metastasizing insuloma].
    Seyer-Hansen K
    Ugeskr Laeger; 1974 Jan; 136(3):153-5. PubMed ID: 4362658
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical and pathological effects of streptozotocin.
    Loftus L; Cuppage FE; Hoogstraten B
    J Lab Clin Med; 1974 Sep; 84(3):407-13. PubMed ID: 4368506
    [No Abstract]   [Full Text] [Related]  

  • 14. [Malignant insuloma. Evaluation of the response to treatment with streptozotocin, using selective arteriography of the celiac axis].
    Neri G; Caresano A; Croce F
    Minerva Med; 1978 Jun; 69(29):1983-90. PubMed ID: 210429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Zollinger-Ellison syndrome and metastatic insulinoma; its response to streptozotocin].
    Agular-Parada E; Rivadeneyra-Hinojosa J; Guzman-Patraca C; Salas-Montero J; Escalante-Herrera A
    Arch Invest Med (Mex); 1977; 8(1):31-8. PubMed ID: 192163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Streptozocin (Zanosar).
    Med Lett Drugs Ther; 1982 Nov; 24(622):100-1. PubMed ID: 6290862
    [No Abstract]   [Full Text] [Related]  

  • 17. Streptozocin alone compared with streptozocin plus fluorouracil in the treatment of advanced islet-cell carcinoma.
    Moertel CG; Hanley JA; Johnson LA
    N Engl J Med; 1980 Nov; 303(21):1189-94. PubMed ID: 6252466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Streptozotocin treatment for malignant insulinoma.
    O'Donnell J; Allen IV; Hunter JC; McIlrath EM; Montgomery DA
    Ir J Med Sci; 1974 May; 143(3):137-44. PubMed ID: 4365474
    [No Abstract]   [Full Text] [Related]  

  • 19. Streptozotocin for non-beta islet-cell cancer.
    DeWys WD
    N Engl J Med; 1973 Jan; 288(3):162. PubMed ID: 4344445
    [No Abstract]   [Full Text] [Related]  

  • 20. [Streptozotocin and malignant insulinomas. Apropos of the case. Review of the literature].
    Beylot J; Veyret V; Vallat I; Longy M; Moretti G
    Sem Hop; 1976 Feb; 52(8):489-96. PubMed ID: 184544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.